UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058363
Receipt number R000066717
Scientific Title Burden of Bowel Movement Problems Study in Patients with Hemodialysis
Date of disclosure of the study information 2025/07/31
Last modified on 2025/07/03 15:55:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Burden of Bowel Movement Problems Study in Patients with Hemodialysis

Acronym

Burden of Bowel Movement Problems Study in Patients with Hemodialysis

Scientific Title

Burden of Bowel Movement Problems Study in Patients with Hemodialysis

Scientific Title:Acronym

Burden of Bowel Movement Problems Study in Patients with Hemodialysis

Region

Japan


Condition

Condition

End-stage kidney disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To reveal patient-reported problems and challenges regarding bowel movement problems in patients with hemodialysis in Japan.

Basic objectives2

Others

Basic objectives -Others

Novel Patient-reported outcomes (PRO) regarding bowel movement problems in patients with hemodialysis in Japan, Patient assessment of constipation quality of life (PAC-QOL)

Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Novel Patient-reported outcomes (PRO) regarding bowel movement problems in patients with hemodialysis in Japan, Patient assessment of constipation quality of life (PAC-QOL)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

A qualitative study
-Patients undergoing outpatient dialysis at Japanese dialysis facilities, aged over 18 years old, and gave informed consent to participation
-Patients feeling about bowel movement problems in their daily living

A quantitative study
-Patients undergoing outpatient dialysis at Japanese dialysis facilities, aged over 18 years old, and gave informed consent to participation

Key exclusion criteria

Patients having structural gastrointestinal diseases
Patients with dementia and psychiatric disorders
Patients using opioids within a month of right before giving informed consent, or at a time of giving informed consent
Patients undergoing chemotherapy within a month of right before giving informed consent, or at a time of giving informed consent
Patients on both hemodialysis and peritoneal dialysis
Patient participating
Patients participating to any clinical trials

Target sample size

212


Research contact person

Name of lead principal investigator

1st name Shin
Middle name
Last name Tokunaga

Organization

Kyowa Kirin Co., Ltd.

Division name

Medical Affairs

Zip code

100-0004

Address

1-9-2, Otemachi, Chiyoda-ku, Tokyo

TEL

03-5205-7200

Email

buenosdias.1g@kyowakirin.com


Public contact

Name of contact person

1st name Shin
Middle name
Last name Tokunaga

Organization

Kyowa Kirin Co., Ltd.

Division name

Medical Affairs

Zip code

100-0004

Address

1-9-2, Otemachi, Chiyoda-ku, Tokyo

TEL

03-5205-7200

Homepage URL


Email

buenosdias.1g@kyowakirin.com


Sponsor or person

Institute

Kyowa Kirin Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Kyowa Kirin Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethical Review Committee of Kyowa Kirin Co., Ltd

Address

1-9-2, Otemachi, Chiyoda-ku, Tokyo

Tel

03-5205-7200

Email

researchethics.fj@kyowakirin.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人社団幸正会岩槻南病院(埼玉県)、医療法人誠仁会なばたけ冬野クリニック(佐賀県)、医療法人社団武蔵野会TMG サテライトクリニック朝霞台(埼玉県)、医療法人友秀会伊丹腎クリニック(北海道)


Other administrative information

Date of disclosure of the study information

2025 Year 07 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 06 Month 19 Day

Date of IRB

2025 Year 06 Month 19 Day

Anticipated trial start date

2025 Year 08 Month 01 Day

Last follow-up date

2026 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2027 Year 01 Month 31 Day


Other

Other related information

Multicenter, cross-sectional, non-interventional, exploratory sequential mixed methods study using semi-structured interviews and questionnaires


Management information

Registered date

2025 Year 07 Month 03 Day

Last modified on

2025 Year 07 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066717